Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
DubaiUAE, 26 January 2025 / CNW/ – on the verge of Arabic health exhibitionYuwell Medical held it 2025 Global Conference of Main Partners IN Dubaiand announced a strategic investment and partnership with inogenAn American leading company in respiratory health, emphasizing our joint commitment to advance medical equipment solutions and deeper cooperation.
Speaking at the Global Conference of YUWELL Medical 2025 partners Alex Wu, leader of Yuwell Medical, stated how a leading enterprise in China The home medical equipment industry, Yuwell will rely on internal growth and foreign unions and purchases to promote internationalization. The company has updated its new vision for the next five years: to become the three key companies in the Global Home Medical Health market in the medium and long term. Among them, respiratory treatment solutions, diabetes care and emergency service solutions are the three main strategic sectors. The company will further strengthen its strategy of globalization from three aspects: expanding the organizational structure, recruiting prominent overseas talent, product innovation and supply chain integration innovation.
He further stressed, “In the process of realizing the new vision, Yuwell will work side by side with global partners to provide users with more competitive products and better health solutions.”
During the conference, Yuwell Medical and US company Inogen formalized their cooperation by signing a Memorandum of Strategic Investment and Cooperationfurther deepening their partnership in respiratory segment.
As one of the world’s largest manufacturers of oxygen concentrators, Yuwell Medical is widely known for its power. R&D skills and advanced manufacturing skills.
Inogen, a major US manufacturer of oxygen concentrators, brings extensive experience in portable oxygen concentrators. Yuwell, through his subsidiary in full ownership of Yuwell (Hong kong) Limited Holdings, has agreed to invest approximately $ 27.2 million In inogen, which represents 9.9% of the circulation of the usual inogenous shares after the closure of this investment.
Both companies seek to improve equipment technology through in -depth cooperation. By combining their expertise and brand in the relevant industry segments and geographies, Yuwell and Inogen agree to perform in -depth strategic cooperation based on business synergy in four aspects: International Distribution Business, Licensing and Trademark Business, Research and joint development and optimization of the supply chain.
